Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Rapport Therapeutics, Inc. | Chief Medical Officer | Common Stock | 197K | Jun 6, 2024 | Direct | ||
Rapport Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 124K | Jun 6, 2024 | Direct | ||
ZOGENIX, INC. | EVP & Chief Medical Officer | Common Stock | 0 | $26.04 | Mar 7, 2022 | Direct | |
ZOGENIX, INC. | EVP & Chief Medical Officer | Restricted Stock Units | 0 | Mar 7, 2022 | Direct | ||
ZOGENIX, INC. | EVP & Chief Medical Officer | Stock Option (Right to Buy) | 0 | $26.09 | Mar 7, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RAPP | Rapport Therapeutics, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Chief Medical Officer |
RAPP | Rapport Therapeutics, Inc. | Jun 6, 2024 | 0 | $0 | 3 | Jun 6, 2024 | Chief Medical Officer |
ZGNX | ZOGENIX, INC. | Mar 7, 2022 | 10 | $0 | 4 | Mar 9, 2022 | EVP & Chief Medical Officer |
ZGNX | ZOGENIX, INC. | Aug 9, 2021 | 1 | $0 | 4 | Aug 11, 2021 | EVP/Chief Medical Officer |